These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 14651845)

  • 1. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
    Hughes-Davies L; Huntsman D; Ruas M; Fuks F; Bye J; Chin SF; Milner J; Brown LA; Hsu F; Gilks B; Nielsen T; Schulzer M; Chia S; Ragaz J; Cahn A; Linger L; Ozdag H; Cattaneo E; Jordanova ES; Schuuring E; Yu DS; Venkitaraman A; Ponder B; Doherty A; Aparicio S; Bentley D; Theillet C; Ponting CP; Caldas C; Kouzarides T
    Cell; 2003 Nov; 115(5):523-35. PubMed ID: 14651845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
    Rodriguez C; Hughes-Davies L; Vallès H; Orsetti B; Cuny M; Ursule L; Kouzarides T; Theillet C
    Clin Cancer Res; 2004 Sep; 10(17):5785-91. PubMed ID: 15355907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
    Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BRCA2-EMSY connection: implications for breast and ovarian tumorigenesis.
    Haber DA
    Cell; 2003 Nov; 115(5):507-8. PubMed ID: 14651841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
    Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
    Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
    Cousineau I; Belmaaza A
    Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EMSY gene in sporadic ovarian cancer.
    Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
    Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of 11q13 in ovarian carcinoma.
    Brown LA; Kalloger SE; Miller MA; Shih IeM; McKinney SE; Santos JL; Swenerton K; Spellman PT; Gray J; Gilks CB; Huntsman DG
    Genes Chromosomes Cancer; 2008 Jun; 47(6):481-9. PubMed ID: 18314909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.
    Raouf A; Brown L; Vrcelj N; To K; Kwok W; Huntsman D; Eaves CJ
    J Natl Cancer Inst; 2005 Sep; 97(17):1302-6. PubMed ID: 16145051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
    Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG
    Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
    Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
    BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of EMSY gene amplification in human cancers.
    Wilkerson PM; Dedes KJ; Wetterskog D; Mackay A; Lambros MB; Mansour M; Frankum J; Lord CJ; Natrajan R; Ashworth A; Reis-Filho JS
    J Pathol; 2011 Sep; 225(1):29-42. PubMed ID: 21735447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
    Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L
    Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMSY links breast cancer gene 2 to the 'Royal Family'.
    Yao J; Polyak K
    Breast Cancer Res; 2004; 6(5):201-3. PubMed ID: 15318925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of EMSY to HP1beta: implications for recruitment of HP1beta and BS69.
    Ekblad CM; Chavali GB; Basu BP; Freund SM; Veprintsev D; Hughes-Davies L; Kouzarides T; Doherty AJ; Itzhaki LS
    EMBO Rep; 2005 Jul; 6(7):675-80. PubMed ID: 15947784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas.
    Madjd Z; Akbari ME; Zarnani AH; Khayamzadeh M; Kalantari E; Mojtabavi N
    Asian Pac J Cancer Prev; 2014; 15(4):1783-9. PubMed ID: 24641409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.
    Hollis RL; Churchman M; Michie CO; Rye T; Knight L; McCavigan A; Perren T; Williams ARW; McCluggage WG; Kaplan RS; Jayson GC; Oza A; Harkin DP; Herrington CS; Kennedy R; Gourley C
    Cancer; 2019 Aug; 125(16):2772-2781. PubMed ID: 31154673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EMSY promoted the growth and migration of ovarian cancer cells.
    Zhao X; Zhou Y; Nie M; Xian S; Chen H; Wen Y; Zhang L; Huang Y; Chen M; Wang S
    Tumour Biol; 2015 Apr; 36(4):3085-92. PubMed ID: 25510665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The function of EMSY in cancer development.
    Hou J; Wang Z; Yang L; Guo X; Yang G
    Tumour Biol; 2014 Jun; 35(6):5061-6. PubMed ID: 24609898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.